Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.
Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.
Amends the current law on health insurance coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment and requires coverage for any medically necessary ovulation-enhancing drugs and medical services.
Prohibits auto insurance companies from using certain race and geographical locations criteria when determining insurance rates.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure, or any generic or brand name prescription drug ordered by a primary care provider.
Mandates all health insurance contracts from January 1, 2026, to cover FDA-approved contraceptives, sterilization, contraception counseling, follow-up services, and a twelve-month supply for Medicaid recipients.
Prohibits insurance companies from paying a rate that is less than the approved Medicaid rate set by the executive office of health and human services.
Prohibits insurance companies from paying a rate that is less than the approved Medicaid rate set by the executive office of health and human services.
Requires individual and group health insurance policies that provide pregnancy-related benefits to cover medically necessary expenses for diagnosis and treatment of infertility and standard fertility-preservation services.
Prohibits the licensing authority from imposing additional or stricter requirements than the department of attorney general as well as prohibiting said licensing authorities from imposing any fees, other than the fee required in ยง 11-47-12.